Episode 6: COVID-19: Repurposing Drugs, Hydroxychloroquine and Clinical Trials

In this episode, the Technology Networks team discuss drug treatments to combat COVID-19. These drugs, like the anti-malarial hydroxychloroquine, have often been repurposed for the task, and evidence for their efficacy remains patchy. Why do researchers turn to these medications and how will the field of drug development be changed by the COVID-19 pandemic? 

Read more from this podcast: 

Hydroxychloroquine Revived by WHO

How modeling can support drug development

Covid-19 brings drug development to a halt

Tackling Covid-19: ongoing drug development efforts

Flooded by the torrent: the COVID-19 drug pipeline

Global impact on clinical trials

What is a preprint? 

Exploring the drug development process

Keep up to date with COVID-19 vaccine development

Updates:

Hydroxychloroquine arm stopped in RECOVERY Trial